Recruiting studies: Stage Iii Nasopharyngeal Carcinoma Ajcc V8

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · 153 location(s) · NRG Oncology · NCT06532279 CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal Carcinoma
Phase 3 · 1 location(s) · Fujian Cancer Hospital · NCT06095154 Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma
NA · 1 location(s) · University of California, San Francisco · NCT06682442 A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
Phase 2 · 85 location(s) · National Cancer Institute (NCI) · NCT06064097 Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastati
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT03010150 Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone i
Phase 2 · 6 location(s) · National Cancer Institute (NCI) · NCT06980038

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.